Particle.news
Download on the App Store

Utah Lets State-Supervised AI Renew Routine Prescriptions in First U.S. Pilot

The yearlong test under a regulatory sandbox measures access with safety guardrails in place.

Overview

  • The Doctronic program went live in December and can autonomously renew about 190–191 common medications for chronic conditions.
  • Exclusions include controlled substances, pain-management and ADHD drugs, and injectables, with uncertain cases escalated to physicians.
  • Patients must verify they are physically in Utah, and doctors review the first 250 renewals in each medication class before full autonomy.
  • Doctronic reports 99.2% concordance with physician plans in 500 urgent-care cases, charges a temporary $4 per refill, and carries malpractice coverage.
  • The AMA warns of safety risks without physician input as the FDA declines to take a position, while the company explores talks with other states and submits outcomes data to Utah.